RWE was essential in understanding and fighting COVID-19, now it must be used to accelerate cancer research

Three reasons why we must continue utilising RWE post-pandemic:

  • RWE studies represent real-world patient populations in real-life settings
  • RWE can elevate patient-centricity (e.g. patient reported outcomes on quality of life)
  • RWE studies identify significant findings more quickly

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: JUL2021BR001